Pulmonary Alveolar Proteinosis Due to Pneumocystis carinii in Type 1 Hyper-IgM Syndrome: A Case Report

Fei Zhou Zhang,Jie Xin Yuan,Lu Qin,Lan Fang Tang
DOI: https://doi.org/10.3389/fped.2020.00264
IF: 3.569
2020-06-11
Frontiers in Pediatrics
Abstract:<span><strong>Background:</strong> Pulmonary alveolar proteinosis (PAP) is a rare diffuse lung disease. Reports of rare cases of PAP due to <i>Pneumocystis jirovecii</i> (<i>P. jirovecii</i>) exist in infants with immunodeficiency diseases, but no cases have been reported to date in pediatric patients with type 1 hyper-IgM syndrome (HIGM1).<strong>Case Presentation:</strong> Herein, we present a case of PAP secondary to <i>P. jirovecii</i> on an infant with HIGM1. He was admitted to our unit because of cough and tachypnea. Lung biopsy confirmed the diagnosis of PAP, whereas hexamine-silver staining of the bronchoalveolar lavage fluid identified <i>P. jirovecii</i> infection. No other probable cause of PAP was observed. Whole exome sequencing indicated a novel c.511dupA (p.I171N<sup>*</sup>30) hemizygous mutation in the CD40 ligand (CD40LG) gene. He was cured with bronchoalveolar lavage and compound sulfamethoxazole tablets.<strong>Conclusions:</strong> To our knowledge, this is the first reported case of <i>P. jirovecii</i> infection as a reversible cause of PAP in an infant with HIGM1.</span>
pediatrics
What problem does this paper attempt to address?